ASP7663 - Moligand™, 10 mM in DMSO , CAS No.1190217-35-6

CAS: 1190217-35-6 Cat. No.: A1493485 Fórmula: C14H14FNO3 Peso molecular: 263.26 PubChem CID: 44232532
Disponível para encomenda
GRAU & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
1ml
A1493485-1ml
Sob encomenda · 8–12 semanas
94,50€
Enter a quantity for the sizes you want to add.

Visão geral

ASP7663 is an orally active and selective TRPA1 agonist. ASP7663 exerts both anti-constipation and anti-abdominal pain actions .

Especificações

Especificações e pureza
Moligand™, 10 mM in DMSO
Condições de armazenamento de armazenamento
Store at -80°C
Enviado em
Dry ice packs + Cold packs
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Grau
Moligand™
Tipo de ação
AGONIST
Nomes e identificadores
SMILES isoméricas
CC(C)CN1C2=C(C=CC=C2F)/C(=C\C(=O)O)/C1=O
CAS alternativo
1190217-35-6
PubChem CID
44232532
Termos de entrada MeSH
(7-fluoro-1-(2-methylpropyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene)acetic acid;ASP7663
Peso molecular
263.26

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Segurança e perigos (GHS)
RIDADR
NONHforallmodesoftransport
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

No tested applications or validated protocols are provided in the product data for this item. The following are general, non-validated guidelines for handling small-molecule tool compounds in discovery workflows.

Suggested general workflow

  • Stock solution: Prepare at 10–50 mM in DMSO. Aliquot into low-bind microtubes to avoid multiple freeze–thaw cycles. Store at −80°C.
  • Plate handling: Thaw aliquots on ice, brief spin, and keep cold during dispensing. Use acoustic or pin-tool transfer to minimize DMSO volume in screening.
  • Final assay concentration: Establish via serial dilution (e.g., 10-point 3-fold) to generate full concentration–response curves. Keep vehicle control matched to max DMSO percentage.
  • Controls: Include positive/negative controls and a counter-screen to detect assay interference or aggregation.
  • Data quality: Monitor Z′ factor, signal window, and check for precipitation or edge effects.

Only adopt detailed parameters after internal validation for your assay platform. For any specific, vendor-validated protocols, consult the CoA/Spec Sheet when available.

Biological Roles

Item-specific biological targets are not provided in the product data. The following information reflects literature context for the compound name and identifiers and must be verified for your intended use.

Literature context (to be verified by the user)

  • ASP7663 has been reported in the literature as a small-molecule modulator used in ion-channel research, with studies describing activity at transient receptor potential (TRP) channels (e.g., TRPA1) as a functional probe. Users should consult primary literature associated with CAS 1190217-35-6 / CID 44232532 for definitive target, potency, and selectivity data relevant to their assays.

General guidance for biological evaluation

  • Establish target engagement and functional consequences using orthogonal assays (binding and activity) to control for assay interference.
  • Profile selectivity against related family members to contextualize off-target risk in cellular systems.
  • Consider chemical liabilities (e.g., aggregation, redox activity, photoreactivity) by incorporating counter-screens (e.g., detergent-sensitivity test, redox cycling assays) as applicable.

Compliance note

  • No clinical or therapeutic claims are made. This product is supplied strictly for research use in laboratory settings.
Buffer Applications

Not typically applicable. ASP7663 is a small-molecule ligand/tool compound and is not used as a buffering agent.

Practical note (general)

  • When preparing assay solutions, dissolve the compound in DMSO (or other suitable solvent) and dilute into your buffer of choice (e.g., HEPES, Tris, or phosphate-based systems) while keeping final organic solvent content within assay tolerance (commonly ≤0.1–0.5% v/v). Verify solubility and absence of precipitation upon dilution.
Green Alternatives

As a discovery ligand, ASP7663 is not typically used in bulk processes where solvent selection drives environmental footprint. Nonetheless, greener practices can be applied to solution preparation, purification, and analytics.

Greener handling suggestions (general)

  • Prefer water-miscible, lower-toxicity solvents for stock preparation when compatible with solubility and assay constraints (e.g., partial substitution of DMSO with ethanol or glycerol–water cosolvents), while carefully validating biological compatibility.
  • Minimize solvent volumes by preparing higher-concentration stocks and using low-retention tips and microvials to reduce waste.
  • Use microscale analytical methods (UPLC, SFC) to decrease solvent consumption versus conventional HPLC.

Comparison (general considerations)

  • DMSO vs ethanol: DMSO offers broader solubility; ethanol is greener but may fail to dissolve highly lipophilic ligands and may perturb assays at lower percentages.
  • DMF vs 2-methyltetrahydrofuran (2-MeTHF): For synthetic steps involving analog preparation, 2-MeTHF is a greener alternative to DMF/THF in certain transformations (literature), but requires solubility and reactivity validation.

Trade-offs

  • Greener solvents can limit solubility or stability; always balance environmental impact with data quality and target compatibility.
Pharmaceutical Uses

No pharmacopeial status or excipient role is provided for this item. ASP7663 is offered for research use only and is not intended for human or veterinary applications.

Research/formulation context (general)

  • In preclinical research, small-molecule tool compounds may be formulated for in vitro and ex vivo studies (e.g., DMSO stocks for cell assays; aqueous vehicles with co-solvents/surfactants for tissue or isolated organ studies). Any in vivo use requires institutionally approved protocols and dedicated grade/materials; this product is not supplied for clinical or diagnostic use.

Manufacturing/CMC note

  • If translating findings, independent sourcing under appropriate GMP or GLP conditions is required. This Moligand™ listing does not imply compliance with pharmacopeial or clinical manufacturing standards.
Physical Properties

Item-specific physicochemical specifications have not been provided in the product data. Where numerical values are needed for method development or QC, consult the CoA/Spec Sheet.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive Index: Not applicable/unknown for solids; Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP / cLogP: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa(s): Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/practice)

  • Small-molecule ligands in discovery programs are commonly formulated as concentrated DMSO stocks (e.g., 10–50 mM) and diluted into assay buffers to ≤0.1–0.5% DMSO v/v final. Ensure solubility and absence of precipitation at working concentrations by visual check or nephelometry.
  • If hygroscopicity or polymorphism is a concern in your workflow, perform a preliminary TGA/DSC or Karl Fischer assessment as appropriate (general guidance; not item-specific).
Quality and Grades
  • Grade/Purity: Moligand™ (Aladdin). This designation indicates the material is intended for use as a small-molecule ligand or tool compound in discovery research and screening. It emphasizes suitability for biochemical/biophysical assays rather than for synthetic transformations requiring preparative purity characterization.

What Moligand™ typically entails (general description)

  • Focus on identity confirmation and assay suitability for library/ligand applications.
  • Packaging designed to support low-temperature storage and minimal freeze–thaw cycling.
  • Documentation: CoA/Spec Sheet provides batch-specific details (purity method, residual solvents, water, etc.).

Item-specific notes

  • Storage Conditions: Store at −80°C (per product data) to maximize stability of the solid and DMSO stocks.
  • Shipped In: Dry ice packs + cold packs to maintain the deep-cold chain.
  • Stabilizers/Inhibitors: Not specified for this item; refer to CoA/Spec Sheet.
  • Specific analytical specifications (e.g., HPLC purity %, UV cutoffs, metal content, residual solvent, water content): Not specified for this item; refer to CoA/Spec Sheet.

Best practices

  • On receipt, inspect seals and temperature indicators. Record lot and open date. Consider orthogonal ID testing (LC–MS, 1H NMR) and purity check (analytical HPLC) before critical studies.
Reaction and Applications

This product is positioned as a small-molecule ligand/tool compound rather than a synthetic reagent. As such, it is generally employed in discovery biology workflows rather than as a substrate or catalyst in chemical reactions.

Typical research applications (general practice)

  • Reference ligand in biochemical, cellular, or biophysical assays (binding, functional readouts, thermal shift/DSF, SPR, MST) for target validation, MoA studies, or benchmarking.
  • Positive control in high-content or electrophysiological assays where applicable (ensure target relevance from your own literature due diligence).
  • SAR support: Use alongside analogs to explore structure–activity trends.
  • Target engagement: CETSA/TS, NanoBRET, or photoaffinity workflows (if compatible) to confirm intracellular engagement.

Practical tips

  • Prepare concentrated DMSO stocks, aliquot, and avoid repeated freeze–thaw to preserve integrity and potency.
  • Confirm purity and identity by LC–MS and analytical HPLC before critical experiments; impurities or degradation can confound biological data.
  • Assess solubility/aggregation at working concentrations; use detergent traces or cyclodextrins as needed and consistent with assay design.

Note: No specific manufacturer application text was provided for this item to further specialize these recommendations.

Reaction Conditions

Not directly applicable. This product is not positioned as a reagent for named synthetic reactions.

General laboratory handling of ligand stocks (practice-based guidance)

  • Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM, vortex and sonicate briefly if needed. Filter (0.2 μm) for biophysical assays sensitive to particulates.
  • Working solutions: Dilute into assay buffer/media to final solvent ≤0.1–0.5% v/v. Mix thoroughly and equilibrate to assay temperature to minimize precipitation.
  • Stability checks: Verify stability by analytical HPLC at time 0 and after typical assay durations (e.g., 2–24 h) at operating temperature. Protect from light if chromophoric groups are suspected (general precaution).

For any custom synthetic modifications of this scaffold, reaction conditions must be developed empirically; no manufacturer-provided conditions are available for this item.

Safety and Handling

Safety data specific to ASP7663 have not been supplied in this listing. Always consult the SDS for authoritative hazard and precautionary statements.

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / H-Statements / Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (good practice)

  • PPE: Wear lab coat, appropriate chemical-resistant gloves (e.g., nitrile), safety glasses or face shield when risk of splashes exists.
  • Engineering controls: Handle powders and stock solutions in a fume hood to avoid inhalation of dust or aerosols. Use ventilated enclosures for weighing if available.
  • Avoid contact with skin/eyes; prevent ingestion and inhalation. Wash thoroughly after handling.
  • Storage incompatibilities: Segregate from strong oxidizers and acids/bases until compatibility is established (general guidance).
  • First aid (overview; defer to SDS): In case of eye/skin contact, rinse with water for several minutes; remove contaminated clothing. If inhaled, move to fresh air. If ingested, rinse mouth and seek medical advice. Provide SDS to responders.
  • Spill response: For small quantities, absorb with inert material (e.g., vermiculite), collect in sealed container for disposal according to institutional and local regulations.
  • Waste: Dispose according to your institution’s hazardous waste program. Avoid sewer release.

Research Use Only: Not for human or veterinary use.

Solvent Selection

No item-specific solubility profile is provided. The following guidance reflects common handling of discovery ligands (general practice):

  • Primary stock solvent: DMSO (high-boiling, polar aprotic) is typically preferred for preparing concentrated stocks (e.g., 10–50 mM), offering broad solubility for drug-like molecules and compatibility with aqueous assay buffers at ≤0.1–0.5% v/v final.
  • Alternative solvents for pre-dissolution: DMF, ethanol, or isopropanol can be used when DMSO is unsuitable, with subsequent dilution into buffer or media. Verify assay tolerance to residual organic solvent.
  • Aqueous media: Many hydrophobic ligands require co-solvent or surfactant (e.g., 0.01–0.05% Tween-20) to avoid precipitation; confirm by visual inspection or nephelometry.

Selection considerations (general)

  • Polarity/miscibility: DMSO is fully miscible with water and most organics; DMF and alcohols are also broadly miscible but may interfere in some biochemical assays.
  • Assay compatibility: Ensure solvent background does not modulate target or detection modality. Run vehicle controls matched to final solvent percentage.
  • Stability: Evaluate compound stability in chosen solvent and at working temperature (e.g., autosampler at 4–10°C) by LC–MS/HPLC over relevant timeframes.

Comparison snapshot (general)

  • DMSO: Maximal solubilizing power; can affect some membrane proteins at ≥1%.
  • Ethanol: Volatile, easy to remove; potential biological effects >0.5%.
  • DMF: Strong solvent; consider toxicity and hygroscopicity.
Storage and Reconstitution

Storage

  • Store at −80°C (per product data). Maintain cold chain upon receipt; product is shipped on dry ice packs + cold packs.
  • Protect from moisture and repeated freeze–thaw. Keep container tightly closed under inert conditions if possible, especially for hygroscopic or air-sensitive solids (general precaution; item-specific sensitivity not provided).

Reconstitution (general guidance for small-molecule ligands)

  • Solvent: Use anhydrous DMSO to prepare concentrated stocks (e.g., 10–50 mM). If alternative solvents are required, verify solubility and assay compatibility.
  • Procedure: Allow vial to equilibrate to room temperature in a desiccated environment before opening to prevent condensation. Accurately weigh, add solvent to target concentration, vortex to dissolve, and, if needed, brief sonication.
  • Aliquoting: Dispense into single-use, low-bind microvials. Minimize headspace. Label with compound ID, lot, concentration, and preparation date.
  • Storage of stocks: Store aliquots at −80°C. Avoid repeated freeze–thaw; discard aliquots after a defined number of thaw cycles (e.g., 1–2) or after stability window determined by your QC.

Stability

  • Item-specific stability data (solution/solid-state, photostability): Not specified for this item; refer to CoA/Spec Sheet. Perform periodic LC–MS/HPLC checks to confirm integrity during use.
Structure and Identity

Brief overview: ASP7663 is a research-only small molecule offered in Aladdin’s Moligand™ grade, typically used as a reference ligand or screening tool compound in discovery biology.

  • SKU: A1493485
  • Product Name: ASP7663
  • CAS: 1190217-35-6
  • PubChem CID: 44232532 (literature identifier)
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Item-specific structural descriptors (ring systems, heteroatoms, stereochemistry): Not specified for this item; refer to CoA/Spec Sheet.

2D structure (verbal description)

  • A definitive 2D structural description cannot be provided from the current product data. For exact atom connectivity and functional groups, consult the CoA/Spec Sheet or authoritative databases linked to the listed CAS/CID (literature reference).
Synthetic Utility

ASP7663 is supplied as a defined small-molecule ligand/tool compound and is not generally used as a synthetic building block.

General remarks for chemists

  • If derivatization is desired for probe development (e.g., biotinylation, photoaffinity, fluorophore tagging), selection of attachment vectors should be guided by SAR from the literature to preserve activity. Conduct parallel synthesis of analogs with careful control experiments to confirm retained function.
  • For analytical characterization of any derivatives, employ LC–MS, HRMS, and 1H/13C NMR. Where solubility is limited, consider mixed deuterated solvents (DMSO-d6/CD3OD) and elevated temperature acquisition.
  • Purification is typically via preparative RP-HPLC for polar/ionizable derivatives or normal-phase chromatography for nonpolar analogs, with attention to potential stereochemical integrity if chiral centers are present (structure not specified here).

Note: No item-specific reactive handles or functional groups are provided in the current product data.

Target Specificity

Item-specific target, selectivity, and potency data are not provided in the product data for this SKU.

  • Target(s): Not specified for this item; refer to CoA/Spec Sheet and primary literature.
  • Species reactivity or panel profiling: Not specified for this item; refer to CoA/Spec Sheet.

Note: Only validated, item-specific information from the manufacturer or CoA should be used for claims of target specificity in formal documentation.

Precisa de ajuda para escolher o grau?

O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.

Ver o guia de graus Moligand™ →

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.